"Universal" Vaccine That Could Work Against 90% of Cancer Types Tested, Baxil Biotherapeutics, Tel Aviv University Study

The therapy, which targets a molecule found in 90 per cent of all cancers, could provide a universal injection that allows patients' immune systems to fight off common cancers including breast and prostate cancer. Preliminary results from early clinical trials have shown the vaccine can trigger an immune response in patients and reduce levels of disease. The scientists behind the vaccine now hope to conduct larger trials in patients to prove it can be effective against a range of different cancers.

Back to news